2023 - Research.com Best Female Scientist Award
2023 - Research.com Best Scientist Award
2023 - Research.com Medicine in Germany Leader Award
2022 - Research.com Best Female Scientist Award
2022 - Research.com Best Scientist Award
2017 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Internal Medicine and Dermatology
Member of the European Molecular Biology Organization (EMBO)
In her works, Stefanie Dimmeler conducts interdisciplinary research on Enzyme and Nitric oxide. Stefanie Dimmeler connects Nitric oxide with Enzyme in her study. Her work on Phosphate expands to the thematically related Organic chemistry. As part of her studies on Phosphate, she frequently links adjacent subjects like Organic chemistry. Her study on Glyceraldehyde is mostly dedicated to connecting different topics, such as Dehydrogenase. Her Dehydrogenase study often links to related topics such as Glyceraldehyde. She frequently studies issues relating to Glyceraldehyde 3-phosphate dehydrogenase and Biochemistry. Her research ties Biochemistry and Glyceraldehyde 3-phosphate dehydrogenase together. By researching both Biotechnology and Genetics, Stefanie Dimmeler produces research that crosses academic boundaries.
Glyceraldehyde 3-phosphate dehydrogenase and Glyceraldehyde are inherently bound to her Dehydrogenase studies. Her work in Glyceraldehyde 3-phosphate dehydrogenase is not limited to one particular discipline; it also encompasses Dehydrogenase. Her studies link Transplantation with Internal medicine. In most of her Transplantation studies, her work intersects topics such as Internal medicine. Her Biochemistry study often links to related topics such as Enzyme assay. Her Genetics study frequently draws connections to adjacent fields such as Vitality. In most of her Vitality studies, her work intersects topics such as Genetics. In her works, Stefanie Dimmeler conducts interdisciplinary research on Cardiology and Gastroenterology. She integrates Gastroenterology with Cardiology in her study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Stefanie Dimmeler;Ingrid Fleming;Beate Fisslthaler;Corinna Hermann.
Endothelial Progenitor Cells: Characterization and Role in Vascular Biology
Carmen Urbich;Stefanie Dimmeler.
Circulation Research (2004)
Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease
Mariuca Vasa;Stephan Fichtlscherer;Alexandra Aicher;Klaudia Adler.
Circulation Research (2001)
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
Birgit Assmus;Volker Schächinger;Claudius Teupe;Martina Britten.
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
Volker Schächinger;Sandra Erbs;Albrecht Elsässer;Werner Haberbosch.
The New England Journal of Medicine (2006)
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
Stefanie Dimmeler;Alexandra Aicher;Mariuca Vasa;Christiane Mildner-Rihm.
Journal of Clinical Investigation (2001)
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.
Volker Schächinger;Birgit Assmus;Martina B. Britten;Jörg Honold.
Journal of the American College of Cardiology (2004)
Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events Proof of Concept for the Clinical Importance of Endogenous Vascular Repair
Caroline Schmidt-Lucke;Lothar Rössig;Stephan Fichtlscherer;Mariuca Vasa.
Transcoronary transplantation of progenitor cells after myocardial infarction.
Birgit Assmus;Jörg Honold;Volker Schächinger;Martina B Britten.
The New England Journal of Medicine (2006)
Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease
Mariuca Vasa;Stephan Fichtlscherer;Klaudia Adler;Alexandra Aicher.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: